Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Plasmodium falciparum artemisinin resistance (ART-R) may have evolved independently in various areas of the Greater Mekong Sub-region (1, 2), prompting the World Health Organization to change its regional policy from containment to elimination (3). Risks associated with ART-R include compromised use of artemisinin combined therapy (ACT), partner drug resistance selection, total ART-R resistance and geographical extension to other malaria endemic regions (2, 3). We therefore need to characterize ART-R in each independent setting and rapidly update the list of ART-R makers.



Emerging Infectious Diseases journal


Centre for Disease Control

Publication Date



Plasmodium falciparum, Ring-stage Survival Assay, K13, malaria, artemisinin resistance, Thai-Myanmar border, parasite clearance half-life